semaglutide heart health Not the biggest fan or user but….this is a breakthrough for many stymied by obesity. Would you use it? “Semaglutide, a GLP-1 receptor agonist from Novo Nordisk, originally developed to treat diabetes Weight-loss drug Wegovy can be

Many natural alternatives have limited high-quality clinical trial data, particularly regarding long-term outcomes and cardiovascular effects

This makes it easier to maintain a calorie deficit over time without the persistent hunger that often undermines dieting

Many patients treated with semaglutide were successful in achieving their desired weight after just one month of consistent use

Most people begin noticing hunger changes between weeks 4-8, with significant appetite reduction at weeks 8-12

If you maintain your current weight during the initiation period, you are on track

Provide results collected within the last 12 months at the time of consultation Collect new labs from any reputable lab